CGTRX
Price
$9.69
Change
-$0.20 (-2.02%)
Updated
Nov 13 closing price
Net Assets
665.47M
GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

CGTRX vs GFACX

Header iconCGTRX vs GFACX Comparison
Open Charts CGTRX vs GFACXBanner chart's image
Columbia Select Large Cap Growth Inst2
Price$9.69
Change-$0.20 (-2.02%)
VolumeN/A
Net Assets665.47M
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
CGTRX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
CGTRX vs. GFACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTRX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. CGTRX (665M). CGTRX (0.00) and GFACX (0.00) have matching dividends . CGTRX was incepted earlier than GFACX: CGTRX (13 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than CGTRX (0.83). CGTRX is a more actively managed with annual turnover of: 40.00 vs. GFACX (25.00). CGTRX has a lower initial minimum investment than GFACX: CGTRX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. CGTRX (-14.17). GFACX return over 5 years is better than : 27.87 vs. CGTRX (-44.31).
CGTRXGFACXCGTRX / GFACX
Total Expense Ratio0.741.3654%
Annual Report Gross Expense Ratio0.831.3661%
Fund Existence13 years25 years-
Gain YTD-4.53216.343-28%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets665M340B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-14.174.61-307%
Returns for 3 years17.8856.1732%
Returns for 5 years-44.3127.87-159%
Returns for 10 years-46.9975.78-62%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics